1. Home
  2. GTLB vs TNGX Comparison

GTLB vs TNGX Comparison

Compare GTLB & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GitLab Inc.

GTLB

GitLab Inc.

N/A

Current Price

$41.67

Market Cap

5.5B

Sector

Technology

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$23.88

Market Cap

4.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTLB
TNGX
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.5B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
GTLB
TNGX
Price
$41.67
$23.88
Analyst Decision
Buy
Strong Buy
Analyst Count
27
10
Target Price
$37.17
$21.78
AVG Volume (30 Days)
4.1M
2.0M
Earning Date
06-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.89
EPS
N/A
N/A
Revenue
$955,224,000.00
$62,384,000.00
Revenue This Year
$18.72
N/A
Revenue Next Year
$16.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.81
48.29
52 Week Low
$18.73
$6.25
52 Week High
$52.38
$34.39

Technical Indicators

Market Signals
Indicator
GTLB
TNGX
Relative Strength Index (RSI) 61.70 35.64
Support Level $36.50 $19.74
Resistance Level $43.00 $25.76
Average True Range (ATR) 1.97 1.47
MACD 0.07 -0.33
Stochastic Oscillator 74.65 8.23

Price Performance

Historical Comparison
GTLB
TNGX

About GTLB GitLab Inc.

GitLab Inc operates on an all-remote model. GitLab is a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation, following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, & the Asia Pacific. It focused on accelerating innovation & broadening the distribution of its platform to companies across the world.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: